Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
JAMA Surgery
|
September 15, 2016
Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
Kelly R Haisley, Amy E Laird, Nima Nabavizadeh, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 6, 2015
Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy
N Nabavizadeh, R Shukla, D A Elliott, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 26, 2015
Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage
Renato A Luna, James P Dolan, Brian S Diggs, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
February 25, 2015
Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy
J P Dolan, T Kaur, B S Diggs, et al.
Cancer Medicine
|
May 3, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma
Emerson Y Chen, Adel Kardosh, Nima Nabavizadeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2022
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
Thomas Yau, Vittorina Zagonel, Armando Santoro, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study
S J Klempner, R A Pazo-Cid, S Lonardi, et al.
ESMO Open
|
June 5, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202
A Vogel, V Sahai, A Hollebecque, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus
Eden G TenBarge, Ashley D Wise, Morgan L Hetzel, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
JAMA Surgery
|
September 15, 2016
Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
Kelly R Haisley, Amy E Laird, Nima Nabavizadeh, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 6, 2015
Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy
N Nabavizadeh, R Shukla, D A Elliott, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 26, 2015
Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage
Renato A Luna, James P Dolan, Brian S Diggs, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
February 25, 2015
Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy
J P Dolan, T Kaur, B S Diggs, et al.
Cancer Medicine
|
May 3, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma
Emerson Y Chen, Adel Kardosh, Nima Nabavizadeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2022
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
Thomas Yau, Vittorina Zagonel, Armando Santoro, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study
S J Klempner, R A Pazo-Cid, S Lonardi, et al.
ESMO Open
|
June 5, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202
A Vogel, V Sahai, A Hollebecque, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus
Eden G TenBarge, Ashley D Wise, Morgan L Hetzel, et al.
Page
of 18